Stay updated with breaking news from Ming Yan. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Cytek’s Cutting-Edge Spectral Flow Cytometry Technology, Specialized Staff, Tools and Solutions Set New Benchmarks for Cell AnalysisFREMONT, Calif. and BARCELONA, Spain, Jan. 17, 2024 -- Cytek...
Cytek Biosciences, Inc. (NASDAQ:CTKB – Get Free Report)’s stock price gapped down before the market opened on Friday . The stock had previously closed at $8.16, but opened at $7.93. Cytek Biosciences shares last traded at $8.09, with a volume of 30,759 shares traded. Analyst Upgrades and Downgrades Several analysts have recently weighed in on […]
Stephens began coverage on shares of Cytek Biosciences (NASDAQ:CTKB – Free Report) in a research report sent to investors on Thursday, MarketBeat.com reports. The brokerage issued an overweight rating and a $9.00 target price on the stock. A number of other brokerages also recently issued reports on CTKB. Piper Sandler decreased their price target on […]
Cytek Biosciences, Inc. (NASDAQ:CTKB – Get Free Report) was the target of a large increase in short interest during the month of November. As of November 15th, there was short interest totalling 8,380,000 shares, an increase of 5.8% from the October 31st total of 7,920,000 shares. Approximately 7.2% of the company’s stock are sold short. […]
Cytek Biosciences, Inc. (NASDAQ:CTKB – Get Free Report) saw a significant growth in short interest in the month of November. As of November 15th, there was short interest totalling 8,380,000 shares, a growth of 5.8% from the October 31st total of 7,920,000 shares. Approximately 7.2% of the shares of the company are sold short. Based […]